Pharma & Healthcare
Global Veterinary Drugs for Companion Animals Market Research Report 2025
- Mar 11, 25
- ID: 29478
- Pages: 88
- Figures: 87
- Views: 17
The global market for Veterinary Drugs for Companion Animals was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Veterinary drugs for companion animals refer to pharmaceutical products that are specifically designed and formulated for use in the treatment, prevention, or management of diseases, conditions, or health issues in pets or companion animals. These drugs are developed to address the unique physiological and medical needs of animals kept as companions, including dogs, cats, birds, rabbits, and other small animals.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 22%.
This report aims to provide a comprehensive presentation of the global market for Veterinary Drugs for Companion Animals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Drugs for Companion Animals.
The Veterinary Drugs for Companion Animals market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Veterinary Drugs for Companion Animals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Drugs for Companion Animals companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis
Boehringer Ingelheim
Merck Animal Health
Elanco Animal Health
Bayer Animal Health
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Meiji
Ouro Fino Saude
Parnell
Segment by Type
Injection
Taking Class
Segment by Application
Farm
Veterinary Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Veterinary Drugs for Companion Animals company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Veterinary drugs for companion animals refer to pharmaceutical products that are specifically designed and formulated for use in the treatment, prevention, or management of diseases, conditions, or health issues in pets or companion animals. These drugs are developed to address the unique physiological and medical needs of animals kept as companions, including dogs, cats, birds, rabbits, and other small animals.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 22%.
This report aims to provide a comprehensive presentation of the global market for Veterinary Drugs for Companion Animals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Drugs for Companion Animals.
The Veterinary Drugs for Companion Animals market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Veterinary Drugs for Companion Animals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Drugs for Companion Animals companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis
Boehringer Ingelheim
Merck Animal Health
Elanco Animal Health
Bayer Animal Health
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Meiji
Ouro Fino Saude
Parnell
Segment by Type
Injection
Taking Class
Segment by Application
Farm
Veterinary Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Veterinary Drugs for Companion Animals company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Veterinary Drugs for Companion Animals Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Injection
1.2.3 Taking Class
1.3 Market by Application
1.3.1 Global Veterinary Drugs for Companion Animals Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Farm
1.3.3 Veterinary Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Veterinary Drugs for Companion Animals Market Perspective (2020-2031)
2.2 Global Veterinary Drugs for Companion Animals Growth Trends by Region
2.2.1 Global Veterinary Drugs for Companion Animals Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Veterinary Drugs for Companion Animals Historic Market Size by Region (2020-2025)
2.2.3 Veterinary Drugs for Companion Animals Forecasted Market Size by Region (2026-2031)
2.3 Veterinary Drugs for Companion Animals Market Dynamics
2.3.1 Veterinary Drugs for Companion Animals Industry Trends
2.3.2 Veterinary Drugs for Companion Animals Market Drivers
2.3.3 Veterinary Drugs for Companion Animals Market Challenges
2.3.4 Veterinary Drugs for Companion Animals Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Veterinary Drugs for Companion Animals Players by Revenue
3.1.1 Global Top Veterinary Drugs for Companion Animals Players by Revenue (2020-2025)
3.1.2 Global Veterinary Drugs for Companion Animals Revenue Market Share by Players (2020-2025)
3.2 Global Veterinary Drugs for Companion Animals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Veterinary Drugs for Companion Animals Revenue
3.4 Global Veterinary Drugs for Companion Animals Market Concentration Ratio
3.4.1 Global Veterinary Drugs for Companion Animals Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Veterinary Drugs for Companion Animals Revenue in 2024
3.5 Global Key Players of Veterinary Drugs for Companion Animals Head office and Area Served
3.6 Global Key Players of Veterinary Drugs for Companion Animals, Product and Application
3.7 Global Key Players of Veterinary Drugs for Companion Animals, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Veterinary Drugs for Companion Animals Breakdown Data by Type
4.1 Global Veterinary Drugs for Companion Animals Historic Market Size by Type (2020-2025)
4.2 Global Veterinary Drugs for Companion Animals Forecasted Market Size by Type (2026-2031)
5 Veterinary Drugs for Companion Animals Breakdown Data by Application
5.1 Global Veterinary Drugs for Companion Animals Historic Market Size by Application (2020-2025)
5.2 Global Veterinary Drugs for Companion Animals Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Veterinary Drugs for Companion Animals Market Size (2020-2031)
6.2 North America Veterinary Drugs for Companion Animals Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Veterinary Drugs for Companion Animals Market Size by Country (2020-2025)
6.4 North America Veterinary Drugs for Companion Animals Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Veterinary Drugs for Companion Animals Market Size (2020-2031)
7.2 Europe Veterinary Drugs for Companion Animals Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Veterinary Drugs for Companion Animals Market Size by Country (2020-2025)
7.4 Europe Veterinary Drugs for Companion Animals Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Veterinary Drugs for Companion Animals Market Size (2020-2031)
8.2 Asia-Pacific Veterinary Drugs for Companion Animals Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Veterinary Drugs for Companion Animals Market Size by Region (2020-2025)
8.4 Asia-Pacific Veterinary Drugs for Companion Animals Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Veterinary Drugs for Companion Animals Market Size (2020-2031)
9.2 Latin America Veterinary Drugs for Companion Animals Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Veterinary Drugs for Companion Animals Market Size by Country (2020-2025)
9.4 Latin America Veterinary Drugs for Companion Animals Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Veterinary Drugs for Companion Animals Market Size (2020-2031)
10.2 Middle East & Africa Veterinary Drugs for Companion Animals Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Veterinary Drugs for Companion Animals Market Size by Country (2020-2025)
10.4 Middle East & Africa Veterinary Drugs for Companion Animals Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Zoetis
11.1.1 Zoetis Company Details
11.1.2 Zoetis Business Overview
11.1.3 Zoetis Veterinary Drugs for Companion Animals Introduction
11.1.4 Zoetis Revenue in Veterinary Drugs for Companion Animals Business (2020-2025)
11.1.5 Zoetis Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Veterinary Drugs for Companion Animals Introduction
11.2.4 Boehringer Ingelheim Revenue in Veterinary Drugs for Companion Animals Business (2020-2025)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Merck Animal Health
11.3.1 Merck Animal Health Company Details
11.3.2 Merck Animal Health Business Overview
11.3.3 Merck Animal Health Veterinary Drugs for Companion Animals Introduction
11.3.4 Merck Animal Health Revenue in Veterinary Drugs for Companion Animals Business (2020-2025)
11.3.5 Merck Animal Health Recent Development
11.4 Elanco Animal Health
11.4.1 Elanco Animal Health Company Details
11.4.2 Elanco Animal Health Business Overview
11.4.3 Elanco Animal Health Veterinary Drugs for Companion Animals Introduction
11.4.4 Elanco Animal Health Revenue in Veterinary Drugs for Companion Animals Business (2020-2025)
11.4.5 Elanco Animal Health Recent Development
11.5 Bayer Animal Health
11.5.1 Bayer Animal Health Company Details
11.5.2 Bayer Animal Health Business Overview
11.5.3 Bayer Animal Health Veterinary Drugs for Companion Animals Introduction
11.5.4 Bayer Animal Health Revenue in Veterinary Drugs for Companion Animals Business (2020-2025)
11.5.5 Bayer Animal Health Recent Development
11.6 Virbac
11.6.1 Virbac Company Details
11.6.2 Virbac Business Overview
11.6.3 Virbac Veterinary Drugs for Companion Animals Introduction
11.6.4 Virbac Revenue in Veterinary Drugs for Companion Animals Business (2020-2025)
11.6.5 Virbac Recent Development
11.7 Dechra Veterinary Products
11.7.1 Dechra Veterinary Products Company Details
11.7.2 Dechra Veterinary Products Business Overview
11.7.3 Dechra Veterinary Products Veterinary Drugs for Companion Animals Introduction
11.7.4 Dechra Veterinary Products Revenue in Veterinary Drugs for Companion Animals Business (2020-2025)
11.7.5 Dechra Veterinary Products Recent Development
11.8 Ceva
11.8.1 Ceva Company Details
11.8.2 Ceva Business Overview
11.8.3 Ceva Veterinary Drugs for Companion Animals Introduction
11.8.4 Ceva Revenue in Veterinary Drugs for Companion Animals Business (2020-2025)
11.8.5 Ceva Recent Development
11.9 Vetoquinol
11.9.1 Vetoquinol Company Details
11.9.2 Vetoquinol Business Overview
11.9.3 Vetoquinol Veterinary Drugs for Companion Animals Introduction
11.9.4 Vetoquinol Revenue in Veterinary Drugs for Companion Animals Business (2020-2025)
11.9.5 Vetoquinol Recent Development
11.10 Meiji
11.10.1 Meiji Company Details
11.10.2 Meiji Business Overview
11.10.3 Meiji Veterinary Drugs for Companion Animals Introduction
11.10.4 Meiji Revenue in Veterinary Drugs for Companion Animals Business (2020-2025)
11.10.5 Meiji Recent Development
11.11 Ouro Fino Saude
11.11.1 Ouro Fino Saude Company Details
11.11.2 Ouro Fino Saude Business Overview
11.11.3 Ouro Fino Saude Veterinary Drugs for Companion Animals Introduction
11.11.4 Ouro Fino Saude Revenue in Veterinary Drugs for Companion Animals Business (2020-2025)
11.11.5 Ouro Fino Saude Recent Development
11.12 Parnell
11.12.1 Parnell Company Details
11.12.2 Parnell Business Overview
11.12.3 Parnell Veterinary Drugs for Companion Animals Introduction
11.12.4 Parnell Revenue in Veterinary Drugs for Companion Animals Business (2020-2025)
11.12.5 Parnell Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Veterinary Drugs for Companion Animals Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Injection
1.2.3 Taking Class
1.3 Market by Application
1.3.1 Global Veterinary Drugs for Companion Animals Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Farm
1.3.3 Veterinary Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Veterinary Drugs for Companion Animals Market Perspective (2020-2031)
2.2 Global Veterinary Drugs for Companion Animals Growth Trends by Region
2.2.1 Global Veterinary Drugs for Companion Animals Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Veterinary Drugs for Companion Animals Historic Market Size by Region (2020-2025)
2.2.3 Veterinary Drugs for Companion Animals Forecasted Market Size by Region (2026-2031)
2.3 Veterinary Drugs for Companion Animals Market Dynamics
2.3.1 Veterinary Drugs for Companion Animals Industry Trends
2.3.2 Veterinary Drugs for Companion Animals Market Drivers
2.3.3 Veterinary Drugs for Companion Animals Market Challenges
2.3.4 Veterinary Drugs for Companion Animals Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Veterinary Drugs for Companion Animals Players by Revenue
3.1.1 Global Top Veterinary Drugs for Companion Animals Players by Revenue (2020-2025)
3.1.2 Global Veterinary Drugs for Companion Animals Revenue Market Share by Players (2020-2025)
3.2 Global Veterinary Drugs for Companion Animals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Veterinary Drugs for Companion Animals Revenue
3.4 Global Veterinary Drugs for Companion Animals Market Concentration Ratio
3.4.1 Global Veterinary Drugs for Companion Animals Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Veterinary Drugs for Companion Animals Revenue in 2024
3.5 Global Key Players of Veterinary Drugs for Companion Animals Head office and Area Served
3.6 Global Key Players of Veterinary Drugs for Companion Animals, Product and Application
3.7 Global Key Players of Veterinary Drugs for Companion Animals, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Veterinary Drugs for Companion Animals Breakdown Data by Type
4.1 Global Veterinary Drugs for Companion Animals Historic Market Size by Type (2020-2025)
4.2 Global Veterinary Drugs for Companion Animals Forecasted Market Size by Type (2026-2031)
5 Veterinary Drugs for Companion Animals Breakdown Data by Application
5.1 Global Veterinary Drugs for Companion Animals Historic Market Size by Application (2020-2025)
5.2 Global Veterinary Drugs for Companion Animals Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Veterinary Drugs for Companion Animals Market Size (2020-2031)
6.2 North America Veterinary Drugs for Companion Animals Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Veterinary Drugs for Companion Animals Market Size by Country (2020-2025)
6.4 North America Veterinary Drugs for Companion Animals Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Veterinary Drugs for Companion Animals Market Size (2020-2031)
7.2 Europe Veterinary Drugs for Companion Animals Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Veterinary Drugs for Companion Animals Market Size by Country (2020-2025)
7.4 Europe Veterinary Drugs for Companion Animals Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Veterinary Drugs for Companion Animals Market Size (2020-2031)
8.2 Asia-Pacific Veterinary Drugs for Companion Animals Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Veterinary Drugs for Companion Animals Market Size by Region (2020-2025)
8.4 Asia-Pacific Veterinary Drugs for Companion Animals Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Veterinary Drugs for Companion Animals Market Size (2020-2031)
9.2 Latin America Veterinary Drugs for Companion Animals Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Veterinary Drugs for Companion Animals Market Size by Country (2020-2025)
9.4 Latin America Veterinary Drugs for Companion Animals Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Veterinary Drugs for Companion Animals Market Size (2020-2031)
10.2 Middle East & Africa Veterinary Drugs for Companion Animals Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Veterinary Drugs for Companion Animals Market Size by Country (2020-2025)
10.4 Middle East & Africa Veterinary Drugs for Companion Animals Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Zoetis
11.1.1 Zoetis Company Details
11.1.2 Zoetis Business Overview
11.1.3 Zoetis Veterinary Drugs for Companion Animals Introduction
11.1.4 Zoetis Revenue in Veterinary Drugs for Companion Animals Business (2020-2025)
11.1.5 Zoetis Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Veterinary Drugs for Companion Animals Introduction
11.2.4 Boehringer Ingelheim Revenue in Veterinary Drugs for Companion Animals Business (2020-2025)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Merck Animal Health
11.3.1 Merck Animal Health Company Details
11.3.2 Merck Animal Health Business Overview
11.3.3 Merck Animal Health Veterinary Drugs for Companion Animals Introduction
11.3.4 Merck Animal Health Revenue in Veterinary Drugs for Companion Animals Business (2020-2025)
11.3.5 Merck Animal Health Recent Development
11.4 Elanco Animal Health
11.4.1 Elanco Animal Health Company Details
11.4.2 Elanco Animal Health Business Overview
11.4.3 Elanco Animal Health Veterinary Drugs for Companion Animals Introduction
11.4.4 Elanco Animal Health Revenue in Veterinary Drugs for Companion Animals Business (2020-2025)
11.4.5 Elanco Animal Health Recent Development
11.5 Bayer Animal Health
11.5.1 Bayer Animal Health Company Details
11.5.2 Bayer Animal Health Business Overview
11.5.3 Bayer Animal Health Veterinary Drugs for Companion Animals Introduction
11.5.4 Bayer Animal Health Revenue in Veterinary Drugs for Companion Animals Business (2020-2025)
11.5.5 Bayer Animal Health Recent Development
11.6 Virbac
11.6.1 Virbac Company Details
11.6.2 Virbac Business Overview
11.6.3 Virbac Veterinary Drugs for Companion Animals Introduction
11.6.4 Virbac Revenue in Veterinary Drugs for Companion Animals Business (2020-2025)
11.6.5 Virbac Recent Development
11.7 Dechra Veterinary Products
11.7.1 Dechra Veterinary Products Company Details
11.7.2 Dechra Veterinary Products Business Overview
11.7.3 Dechra Veterinary Products Veterinary Drugs for Companion Animals Introduction
11.7.4 Dechra Veterinary Products Revenue in Veterinary Drugs for Companion Animals Business (2020-2025)
11.7.5 Dechra Veterinary Products Recent Development
11.8 Ceva
11.8.1 Ceva Company Details
11.8.2 Ceva Business Overview
11.8.3 Ceva Veterinary Drugs for Companion Animals Introduction
11.8.4 Ceva Revenue in Veterinary Drugs for Companion Animals Business (2020-2025)
11.8.5 Ceva Recent Development
11.9 Vetoquinol
11.9.1 Vetoquinol Company Details
11.9.2 Vetoquinol Business Overview
11.9.3 Vetoquinol Veterinary Drugs for Companion Animals Introduction
11.9.4 Vetoquinol Revenue in Veterinary Drugs for Companion Animals Business (2020-2025)
11.9.5 Vetoquinol Recent Development
11.10 Meiji
11.10.1 Meiji Company Details
11.10.2 Meiji Business Overview
11.10.3 Meiji Veterinary Drugs for Companion Animals Introduction
11.10.4 Meiji Revenue in Veterinary Drugs for Companion Animals Business (2020-2025)
11.10.5 Meiji Recent Development
11.11 Ouro Fino Saude
11.11.1 Ouro Fino Saude Company Details
11.11.2 Ouro Fino Saude Business Overview
11.11.3 Ouro Fino Saude Veterinary Drugs for Companion Animals Introduction
11.11.4 Ouro Fino Saude Revenue in Veterinary Drugs for Companion Animals Business (2020-2025)
11.11.5 Ouro Fino Saude Recent Development
11.12 Parnell
11.12.1 Parnell Company Details
11.12.2 Parnell Business Overview
11.12.3 Parnell Veterinary Drugs for Companion Animals Introduction
11.12.4 Parnell Revenue in Veterinary Drugs for Companion Animals Business (2020-2025)
11.12.5 Parnell Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Veterinary Drugs for Companion Animals Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Injection
Table 3. Key Players of Taking Class
Table 4. Global Veterinary Drugs for Companion Animals Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Veterinary Drugs for Companion Animals Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Veterinary Drugs for Companion Animals Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Veterinary Drugs for Companion Animals Market Share by Region (2020-2025)
Table 8. Global Veterinary Drugs for Companion Animals Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Veterinary Drugs for Companion Animals Market Share by Region (2026-2031)
Table 10. Veterinary Drugs for Companion Animals Market Trends
Table 11. Veterinary Drugs for Companion Animals Market Drivers
Table 12. Veterinary Drugs for Companion Animals Market Challenges
Table 13. Veterinary Drugs for Companion Animals Market Restraints
Table 14. Global Veterinary Drugs for Companion Animals Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Veterinary Drugs for Companion Animals Market Share by Players (2020-2025)
Table 16. Global Top Veterinary Drugs for Companion Animals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Drugs for Companion Animals as of 2024)
Table 17. Ranking of Global Top Veterinary Drugs for Companion Animals Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Veterinary Drugs for Companion Animals Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Veterinary Drugs for Companion Animals, Headquarters and Area Served
Table 20. Global Key Players of Veterinary Drugs for Companion Animals, Product and Application
Table 21. Global Key Players of Veterinary Drugs for Companion Animals, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Veterinary Drugs for Companion Animals Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Veterinary Drugs for Companion Animals Revenue Market Share by Type (2020-2025)
Table 25. Global Veterinary Drugs for Companion Animals Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Veterinary Drugs for Companion Animals Revenue Market Share by Type (2026-2031)
Table 27. Global Veterinary Drugs for Companion Animals Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Veterinary Drugs for Companion Animals Revenue Market Share by Application (2020-2025)
Table 29. Global Veterinary Drugs for Companion Animals Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Veterinary Drugs for Companion Animals Revenue Market Share by Application (2026-2031)
Table 31. North America Veterinary Drugs for Companion Animals Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Veterinary Drugs for Companion Animals Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Veterinary Drugs for Companion Animals Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Veterinary Drugs for Companion Animals Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Veterinary Drugs for Companion Animals Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Veterinary Drugs for Companion Animals Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Veterinary Drugs for Companion Animals Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Veterinary Drugs for Companion Animals Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Veterinary Drugs for Companion Animals Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Veterinary Drugs for Companion Animals Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Veterinary Drugs for Companion Animals Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Veterinary Drugs for Companion Animals Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Veterinary Drugs for Companion Animals Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Veterinary Drugs for Companion Animals Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Veterinary Drugs for Companion Animals Market Size by Country (2026-2031) & (US$ Million)
Table 46. Zoetis Company Details
Table 47. Zoetis Business Overview
Table 48. Zoetis Veterinary Drugs for Companion Animals Product
Table 49. Zoetis Revenue in Veterinary Drugs for Companion Animals Business (2020-2025) & (US$ Million)
Table 50. Zoetis Recent Development
Table 51. Boehringer Ingelheim Company Details
Table 52. Boehringer Ingelheim Business Overview
Table 53. Boehringer Ingelheim Veterinary Drugs for Companion Animals Product
Table 54. Boehringer Ingelheim Revenue in Veterinary Drugs for Companion Animals Business (2020-2025) & (US$ Million)
Table 55. Boehringer Ingelheim Recent Development
Table 56. Merck Animal Health Company Details
Table 57. Merck Animal Health Business Overview
Table 58. Merck Animal Health Veterinary Drugs for Companion Animals Product
Table 59. Merck Animal Health Revenue in Veterinary Drugs for Companion Animals Business (2020-2025) & (US$ Million)
Table 60. Merck Animal Health Recent Development
Table 61. Elanco Animal Health Company Details
Table 62. Elanco Animal Health Business Overview
Table 63. Elanco Animal Health Veterinary Drugs for Companion Animals Product
Table 64. Elanco Animal Health Revenue in Veterinary Drugs for Companion Animals Business (2020-2025) & (US$ Million)
Table 65. Elanco Animal Health Recent Development
Table 66. Bayer Animal Health Company Details
Table 67. Bayer Animal Health Business Overview
Table 68. Bayer Animal Health Veterinary Drugs for Companion Animals Product
Table 69. Bayer Animal Health Revenue in Veterinary Drugs for Companion Animals Business (2020-2025) & (US$ Million)
Table 70. Bayer Animal Health Recent Development
Table 71. Virbac Company Details
Table 72. Virbac Business Overview
Table 73. Virbac Veterinary Drugs for Companion Animals Product
Table 74. Virbac Revenue in Veterinary Drugs for Companion Animals Business (2020-2025) & (US$ Million)
Table 75. Virbac Recent Development
Table 76. Dechra Veterinary Products Company Details
Table 77. Dechra Veterinary Products Business Overview
Table 78. Dechra Veterinary Products Veterinary Drugs for Companion Animals Product
Table 79. Dechra Veterinary Products Revenue in Veterinary Drugs for Companion Animals Business (2020-2025) & (US$ Million)
Table 80. Dechra Veterinary Products Recent Development
Table 81. Ceva Company Details
Table 82. Ceva Business Overview
Table 83. Ceva Veterinary Drugs for Companion Animals Product
Table 84. Ceva Revenue in Veterinary Drugs for Companion Animals Business (2020-2025) & (US$ Million)
Table 85. Ceva Recent Development
Table 86. Vetoquinol Company Details
Table 87. Vetoquinol Business Overview
Table 88. Vetoquinol Veterinary Drugs for Companion Animals Product
Table 89. Vetoquinol Revenue in Veterinary Drugs for Companion Animals Business (2020-2025) & (US$ Million)
Table 90. Vetoquinol Recent Development
Table 91. Meiji Company Details
Table 92. Meiji Business Overview
Table 93. Meiji Veterinary Drugs for Companion Animals Product
Table 94. Meiji Revenue in Veterinary Drugs for Companion Animals Business (2020-2025) & (US$ Million)
Table 95. Meiji Recent Development
Table 96. Ouro Fino Saude Company Details
Table 97. Ouro Fino Saude Business Overview
Table 98. Ouro Fino Saude Veterinary Drugs for Companion Animals Product
Table 99. Ouro Fino Saude Revenue in Veterinary Drugs for Companion Animals Business (2020-2025) & (US$ Million)
Table 100. Ouro Fino Saude Recent Development
Table 101. Parnell Company Details
Table 102. Parnell Business Overview
Table 103. Parnell Veterinary Drugs for Companion Animals Product
Table 104. Parnell Revenue in Veterinary Drugs for Companion Animals Business (2020-2025) & (US$ Million)
Table 105. Parnell Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Veterinary Drugs for Companion Animals Picture
Figure 2. Global Veterinary Drugs for Companion Animals Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Veterinary Drugs for Companion Animals Market Share by Type: 2024 VS 2031
Figure 4. Injection Features
Figure 5. Taking Class Features
Figure 6. Global Veterinary Drugs for Companion Animals Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Veterinary Drugs for Companion Animals Market Share by Application: 2024 VS 2031
Figure 8. Farm Case Studies
Figure 9. Veterinary Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Veterinary Drugs for Companion Animals Report Years Considered
Figure 12. Global Veterinary Drugs for Companion Animals Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Veterinary Drugs for Companion Animals Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Veterinary Drugs for Companion Animals Market Share by Region: 2024 VS 2031
Figure 15. Global Veterinary Drugs for Companion Animals Market Share by Players in 2024
Figure 16. Global Top Veterinary Drugs for Companion Animals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Drugs for Companion Animals as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Veterinary Drugs for Companion Animals Revenue in 2024
Figure 18. North America Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Veterinary Drugs for Companion Animals Market Share by Country (2020-2031)
Figure 20. United States Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Veterinary Drugs for Companion Animals Market Share by Country (2020-2031)
Figure 24. Germany Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Veterinary Drugs for Companion Animals Market Share by Region (2020-2031)
Figure 32. China Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Veterinary Drugs for Companion Animals Market Share by Country (2020-2031)
Figure 40. Mexico Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Veterinary Drugs for Companion Animals Market Share by Country (2020-2031)
Figure 44. Turkey Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Zoetis Revenue Growth Rate in Veterinary Drugs for Companion Animals Business (2020-2025)
Figure 48. Boehringer Ingelheim Revenue Growth Rate in Veterinary Drugs for Companion Animals Business (2020-2025)
Figure 49. Merck Animal Health Revenue Growth Rate in Veterinary Drugs for Companion Animals Business (2020-2025)
Figure 50. Elanco Animal Health Revenue Growth Rate in Veterinary Drugs for Companion Animals Business (2020-2025)
Figure 51. Bayer Animal Health Revenue Growth Rate in Veterinary Drugs for Companion Animals Business (2020-2025)
Figure 52. Virbac Revenue Growth Rate in Veterinary Drugs for Companion Animals Business (2020-2025)
Figure 53. Dechra Veterinary Products Revenue Growth Rate in Veterinary Drugs for Companion Animals Business (2020-2025)
Figure 54. Ceva Revenue Growth Rate in Veterinary Drugs for Companion Animals Business (2020-2025)
Figure 55. Vetoquinol Revenue Growth Rate in Veterinary Drugs for Companion Animals Business (2020-2025)
Figure 56. Meiji Revenue Growth Rate in Veterinary Drugs for Companion Animals Business (2020-2025)
Figure 57. Ouro Fino Saude Revenue Growth Rate in Veterinary Drugs for Companion Animals Business (2020-2025)
Figure 58. Parnell Revenue Growth Rate in Veterinary Drugs for Companion Animals Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Veterinary Drugs for Companion Animals Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Injection
Table 3. Key Players of Taking Class
Table 4. Global Veterinary Drugs for Companion Animals Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Veterinary Drugs for Companion Animals Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Veterinary Drugs for Companion Animals Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Veterinary Drugs for Companion Animals Market Share by Region (2020-2025)
Table 8. Global Veterinary Drugs for Companion Animals Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Veterinary Drugs for Companion Animals Market Share by Region (2026-2031)
Table 10. Veterinary Drugs for Companion Animals Market Trends
Table 11. Veterinary Drugs for Companion Animals Market Drivers
Table 12. Veterinary Drugs for Companion Animals Market Challenges
Table 13. Veterinary Drugs for Companion Animals Market Restraints
Table 14. Global Veterinary Drugs for Companion Animals Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Veterinary Drugs for Companion Animals Market Share by Players (2020-2025)
Table 16. Global Top Veterinary Drugs for Companion Animals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Drugs for Companion Animals as of 2024)
Table 17. Ranking of Global Top Veterinary Drugs for Companion Animals Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Veterinary Drugs for Companion Animals Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Veterinary Drugs for Companion Animals, Headquarters and Area Served
Table 20. Global Key Players of Veterinary Drugs for Companion Animals, Product and Application
Table 21. Global Key Players of Veterinary Drugs for Companion Animals, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Veterinary Drugs for Companion Animals Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Veterinary Drugs for Companion Animals Revenue Market Share by Type (2020-2025)
Table 25. Global Veterinary Drugs for Companion Animals Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Veterinary Drugs for Companion Animals Revenue Market Share by Type (2026-2031)
Table 27. Global Veterinary Drugs for Companion Animals Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Veterinary Drugs for Companion Animals Revenue Market Share by Application (2020-2025)
Table 29. Global Veterinary Drugs for Companion Animals Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Veterinary Drugs for Companion Animals Revenue Market Share by Application (2026-2031)
Table 31. North America Veterinary Drugs for Companion Animals Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Veterinary Drugs for Companion Animals Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Veterinary Drugs for Companion Animals Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Veterinary Drugs for Companion Animals Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Veterinary Drugs for Companion Animals Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Veterinary Drugs for Companion Animals Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Veterinary Drugs for Companion Animals Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Veterinary Drugs for Companion Animals Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Veterinary Drugs for Companion Animals Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Veterinary Drugs for Companion Animals Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Veterinary Drugs for Companion Animals Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Veterinary Drugs for Companion Animals Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Veterinary Drugs for Companion Animals Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Veterinary Drugs for Companion Animals Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Veterinary Drugs for Companion Animals Market Size by Country (2026-2031) & (US$ Million)
Table 46. Zoetis Company Details
Table 47. Zoetis Business Overview
Table 48. Zoetis Veterinary Drugs for Companion Animals Product
Table 49. Zoetis Revenue in Veterinary Drugs for Companion Animals Business (2020-2025) & (US$ Million)
Table 50. Zoetis Recent Development
Table 51. Boehringer Ingelheim Company Details
Table 52. Boehringer Ingelheim Business Overview
Table 53. Boehringer Ingelheim Veterinary Drugs for Companion Animals Product
Table 54. Boehringer Ingelheim Revenue in Veterinary Drugs for Companion Animals Business (2020-2025) & (US$ Million)
Table 55. Boehringer Ingelheim Recent Development
Table 56. Merck Animal Health Company Details
Table 57. Merck Animal Health Business Overview
Table 58. Merck Animal Health Veterinary Drugs for Companion Animals Product
Table 59. Merck Animal Health Revenue in Veterinary Drugs for Companion Animals Business (2020-2025) & (US$ Million)
Table 60. Merck Animal Health Recent Development
Table 61. Elanco Animal Health Company Details
Table 62. Elanco Animal Health Business Overview
Table 63. Elanco Animal Health Veterinary Drugs for Companion Animals Product
Table 64. Elanco Animal Health Revenue in Veterinary Drugs for Companion Animals Business (2020-2025) & (US$ Million)
Table 65. Elanco Animal Health Recent Development
Table 66. Bayer Animal Health Company Details
Table 67. Bayer Animal Health Business Overview
Table 68. Bayer Animal Health Veterinary Drugs for Companion Animals Product
Table 69. Bayer Animal Health Revenue in Veterinary Drugs for Companion Animals Business (2020-2025) & (US$ Million)
Table 70. Bayer Animal Health Recent Development
Table 71. Virbac Company Details
Table 72. Virbac Business Overview
Table 73. Virbac Veterinary Drugs for Companion Animals Product
Table 74. Virbac Revenue in Veterinary Drugs for Companion Animals Business (2020-2025) & (US$ Million)
Table 75. Virbac Recent Development
Table 76. Dechra Veterinary Products Company Details
Table 77. Dechra Veterinary Products Business Overview
Table 78. Dechra Veterinary Products Veterinary Drugs for Companion Animals Product
Table 79. Dechra Veterinary Products Revenue in Veterinary Drugs for Companion Animals Business (2020-2025) & (US$ Million)
Table 80. Dechra Veterinary Products Recent Development
Table 81. Ceva Company Details
Table 82. Ceva Business Overview
Table 83. Ceva Veterinary Drugs for Companion Animals Product
Table 84. Ceva Revenue in Veterinary Drugs for Companion Animals Business (2020-2025) & (US$ Million)
Table 85. Ceva Recent Development
Table 86. Vetoquinol Company Details
Table 87. Vetoquinol Business Overview
Table 88. Vetoquinol Veterinary Drugs for Companion Animals Product
Table 89. Vetoquinol Revenue in Veterinary Drugs for Companion Animals Business (2020-2025) & (US$ Million)
Table 90. Vetoquinol Recent Development
Table 91. Meiji Company Details
Table 92. Meiji Business Overview
Table 93. Meiji Veterinary Drugs for Companion Animals Product
Table 94. Meiji Revenue in Veterinary Drugs for Companion Animals Business (2020-2025) & (US$ Million)
Table 95. Meiji Recent Development
Table 96. Ouro Fino Saude Company Details
Table 97. Ouro Fino Saude Business Overview
Table 98. Ouro Fino Saude Veterinary Drugs for Companion Animals Product
Table 99. Ouro Fino Saude Revenue in Veterinary Drugs for Companion Animals Business (2020-2025) & (US$ Million)
Table 100. Ouro Fino Saude Recent Development
Table 101. Parnell Company Details
Table 102. Parnell Business Overview
Table 103. Parnell Veterinary Drugs for Companion Animals Product
Table 104. Parnell Revenue in Veterinary Drugs for Companion Animals Business (2020-2025) & (US$ Million)
Table 105. Parnell Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Veterinary Drugs for Companion Animals Picture
Figure 2. Global Veterinary Drugs for Companion Animals Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Veterinary Drugs for Companion Animals Market Share by Type: 2024 VS 2031
Figure 4. Injection Features
Figure 5. Taking Class Features
Figure 6. Global Veterinary Drugs for Companion Animals Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Veterinary Drugs for Companion Animals Market Share by Application: 2024 VS 2031
Figure 8. Farm Case Studies
Figure 9. Veterinary Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Veterinary Drugs for Companion Animals Report Years Considered
Figure 12. Global Veterinary Drugs for Companion Animals Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Veterinary Drugs for Companion Animals Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Veterinary Drugs for Companion Animals Market Share by Region: 2024 VS 2031
Figure 15. Global Veterinary Drugs for Companion Animals Market Share by Players in 2024
Figure 16. Global Top Veterinary Drugs for Companion Animals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Drugs for Companion Animals as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Veterinary Drugs for Companion Animals Revenue in 2024
Figure 18. North America Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Veterinary Drugs for Companion Animals Market Share by Country (2020-2031)
Figure 20. United States Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Veterinary Drugs for Companion Animals Market Share by Country (2020-2031)
Figure 24. Germany Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Veterinary Drugs for Companion Animals Market Share by Region (2020-2031)
Figure 32. China Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Veterinary Drugs for Companion Animals Market Share by Country (2020-2031)
Figure 40. Mexico Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Veterinary Drugs for Companion Animals Market Share by Country (2020-2031)
Figure 44. Turkey Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Veterinary Drugs for Companion Animals Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Zoetis Revenue Growth Rate in Veterinary Drugs for Companion Animals Business (2020-2025)
Figure 48. Boehringer Ingelheim Revenue Growth Rate in Veterinary Drugs for Companion Animals Business (2020-2025)
Figure 49. Merck Animal Health Revenue Growth Rate in Veterinary Drugs for Companion Animals Business (2020-2025)
Figure 50. Elanco Animal Health Revenue Growth Rate in Veterinary Drugs for Companion Animals Business (2020-2025)
Figure 51. Bayer Animal Health Revenue Growth Rate in Veterinary Drugs for Companion Animals Business (2020-2025)
Figure 52. Virbac Revenue Growth Rate in Veterinary Drugs for Companion Animals Business (2020-2025)
Figure 53. Dechra Veterinary Products Revenue Growth Rate in Veterinary Drugs for Companion Animals Business (2020-2025)
Figure 54. Ceva Revenue Growth Rate in Veterinary Drugs for Companion Animals Business (2020-2025)
Figure 55. Vetoquinol Revenue Growth Rate in Veterinary Drugs for Companion Animals Business (2020-2025)
Figure 56. Meiji Revenue Growth Rate in Veterinary Drugs for Companion Animals Business (2020-2025)
Figure 57. Ouro Fino Saude Revenue Growth Rate in Veterinary Drugs for Companion Animals Business (2020-2025)
Figure 58. Parnell Revenue Growth Rate in Veterinary Drugs for Companion Animals Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Benzyltrimethylammonium Hydroxide (BTMAH) Market Research Report 2025
Jul 10, 25
Global Allyltrimethylammonium Chloride Market Research Report 2025
Jul 10, 25
Global Calcium Bisglycinate Market Research Report 2025
Jul 10, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232